Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Clinical Investigation

• Publication date

  2003-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI17808PMID 12840058PMCID PMC162289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.

  2002cited by this paper
• Molecular profiling of angiogenesis markers.

  2002cited by this paper
• Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis

  2002cited by this paper
• Placental growth factor is a survival factor for tumor endothelial cells and macrophages.

  2002cited by this paper
• Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin

  2002cited by this paper
• Placenta Growth Factor

  2001cited by this paper
• Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development.

  2001cited by this paper
• Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

  2001cited by this paper
• Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.

  2001cited by this paper
• A novel vascular endothelial growth factor encoded by Orf virus, VEGF‐E, mediates angiogenesis via signalling through VEGFR‐2 (KDR) but not VEGFR‐1 (Flt‐1) receptor tyrosine kinases

  1999cited by this paper
• Structure, expression and receptor-binding properties of placenta growth factor (PlGF).

  1999cited by this paper
• Expression of vascular endothelial growth factor and its receptor, KDR, following retinal ischemia-reperfusion injury in the rat.

  1998cited by this paper
• Neuropilin-1 Is a Placenta Growth Factor-2 Receptor*

  1998cited by this paper
• A Novel Type of Vascular Endothelial Growth Factor, VEGF-E (NZ-7 VEGF), Preferentially Utilizes KDR/Flk-1 Receptor and Carries a Potent Mitotic Activity without Heparin-binding Domain*

  1998cited by this paper
• [Retinopathy of prematurity].

  1998cited by this paper
• Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization.

  1998cited by this paper
• Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.

  1998cited by this paper
• Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.

  1996cited by this paper
• Flk-1, a Receptor for Vascular Endothelial Growth Factor (VEGF), Is Expressed by Retinal Progenitor Cells

  1996cited by this paper
• Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

  1995cited by this paper
• Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity

  1995cited by this paper
• Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.

  1994cited by this paper
• Oxygen-induced retinopathy in the mouse.

  1994influential reference
• Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

  1993cited by this paper
• Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse.

  1993influential reference
• Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic.

  1990cited by this paper
• Retinopathy of prematurity.

  1986cited by this paper
• DEVELOPMENTAL NEUROSCIENCE: Postnatal expression of VEGF and its receptor flk-1 in peripheral ganglia

  year unknowncited by this paper

• Systemic targeting of aberrant neovascular tufts using trehalose-dendrimer nanocarriers for the treatment of proliferative retinopathies

  2026cites this paper
• Endothelial MEMO1 Regulates Angiogenic Signaling in a Model of Retinopathy of Prematurity

  2025cites this paper
• Retinopathy of Prematurity—Targeting Hypoxic and Redox Signaling Pathways

  2024cites this paper
• Analysis of trends in retinopathy of prematurity over 5 years in a tertiary neonatal intensive care unit

  2023cites this paper
• Postnatal hyperglycemia alters amino acid profile in retinas (model of Phase I ROP)

  2023cites this paper
• Critical Role of VEGF as a Direct Regulator of Photoreceptor Function.

  2023cites this paper
• Role of the Endothelium in Neonatal Diseases

  2022cites this paper
• Retinopathy of prematurity: Metabolic risk factors

  2022cites this paper
• Retinopathy of prematurity: A review of pathophysiology and signaling Pathways

  2022cites this paper
• Retinopathy of prematurity shows alterations in Vegfa164 isoform expression

  2021cites this paper
• Serum levels of placental growth factor reflect the severity of retinopathy of prematurity

  2021cites this paper
• Retinal Vascular Disease

  2021cites this paper
• Contribution of cell death signaling to blood vessel formation

  2021cites this paper
• Diabetic macular ischaemia- a new therapeutic target?

  2021cites this paper
• Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity

  2021influential citation
• Adenosine A2A receptor antagonism protects against hyperoxia‐induced retinal vascular loss via cellular proliferation

  2021cites this paper
• VEGF as a Direct Functional Regulator of Photoreceptors and Contributing Factor to Diabetes-Induced Alteration of Photoreceptor Function

  2021cites this paper
• Rétinopathie du prématuré : de la prévention au traitement

  2020cites this paper
• Pericyte-Endothelial Interactions in the Retinal Microvasculature

  2020cites this paper
• Retinal Drug Delivery: Rethinking Outcomes for the Efficient Replication of Retinal Behavior

  2020cites this paper
• VEGF‐Trap is a potent modulator of vasoregenerative responses and protects dopaminergic amacrine network integrity in degenerative ischemic neovascular retinopathy

  2020cites this paper
• [Retinopathy of prematurity: from prevention to treatment].

  2020cites this paper
• Blue-violet light decreases VEGFa production in an in vitro model of AMD

  2019cites this paper
• The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases

  2019cites this paper
• Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis

  2019cites this paper
• Blood Vessel Patterning on Retinal Astrocytes Requires Endothelial Flt-1 (VEGFR-1)

  2019cites this paper
• Postnatal weight gain and retinopathy of prematurity.

  2019cites this paper
• The pericyte microenvironment during vascular development

  2019cites this paper
• A review of treatment for retinopathy of prematurity

  2019cites this paper
• A collagen IV – derived peptide disrupts a 5 b 1 integrin and potentiates Ang 2 / Tie 2 signaling

  2019cites this paper
• Microvascular bioengineering: a focus on pericytes

  2019cites this paper
• A collagen IV-derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling.

  2019cites this paper
• The role of the retinal pigment epithelium and Müller cells secretome in neovascular retinal pathologies.

  2018cites this paper
• The progress of prophylactic treatment in retinopathy of prematurity.

  2018cites this paper
• Exploitation of receptor tyrosine kinases by viral-encoded growth factors

  2018cites this paper
• Long-lasting impairments in rodent oxygen-induced retinopathy measured by retinal vessel density and visual function

  2018cites this paper
• Title Placental growth factor and its potential role in diabeticretinopathy and other ocular neovascular diseases

  2018cites this paper
• Prediction Models for Retinopathy of Prematurity

  2018cites this paper
• Effect of intravitreal bevacizumab on macular thickness: exploring serum and vitreous proangiogenic biomarkers in patients with diabetic macular edema

  2018cites this paper
• Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation

  2018cites this paper
• Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1

  2017cites this paper
• Anti-angiogenic Therapy for Retinal Disease.

  2017cites this paper
• Advances in understanding and management of retinopathy of prematurity.

  2017cites this paper
• 46 – Rétinopathie du prématuré : concepts actuels, stratégies de prise en charge

  2017cites this paper
• Insulin-like Growth Factor I ( IGF-I ) as a Predictive Factor of Retinopathy of Prematurity

  2017cites this paper
• The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity

  2017cites this paper
• Pharmacologic Therapy of Ocular Disease

  2017cites this paper
• Hyperoxia-Induced Proliferative Retinopathy: Early Interruption of Retinal Vascular Development with Severe and Irreversible Neurovascular Disruption

  2016cites this paper
• Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.

  2016cites this paper
• Impaired angiogenesis in the enalapril-treated neonatal rat kidney

  2016cites this paper
• Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases

  2016cites this paper
• Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy

  2015cites this paper
• The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease

  2015cites this paper
• POSTNATAL SERUM INSULIN-LIKE GROWTH FACTOR I AND RETINOPATHY OF PREMATURITY

  2015cites this paper
• Deletion of SPARC Enhances Retinal Vaso-Obliteration in Mouse Model of Oxygen-Induced Retinopathy.

  2014cites this paper
• Study on vascular endothelial growth factor and its receptor in the vitreous of diabetic rats.

  2014cites this paper
• Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.

  2014cites this paper
• The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge

  2014cites this paper
• Algorithms for the prediction of retinopathy of prematurity based on postnatal weight gain.

  2013cites this paper
• Placental Growth Factor Inhibition for Choroidal Neovascularization

  2013cites this paper
• The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment.

  2013cites this paper
• Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.

  2013cites this paper
• Isoxanthohumol modulates angiogenesis and inflammation via vascular endothelial growth factor receptor, tumor necrosis factor alpha and nuclear factor kappa B pathways.

  2013cites this paper
• The Biology of Retinopathy of Prematurity

  2013cites this paper
• Complicated life, complicated VEGF-B.

  2012cites this paper
• Retinopathy of prematurity: Where are we today?

  2012cites this paper
• The cysteinyl leukotriene 2 receptor mediates retinal edema and pathological neovascularization in a murine model of oxygen‐induced retinopathy

  2012cites this paper
• PlGF: a multitasking cytokine with disease-restricted activity.

  2012cites this paper
• Effect of Triamcinolone on Retinal Vessel-Related Factors in Oxygen-Induced Retinopathy Rats

  2012cites this paper
• A Clinical Prediction Model to Stratify Retinopathy of Prematurity Risk Using Postnatal Weight Gain

  2011cites this paper
• Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity.

  2011cites this paper
• Placenta Growth Factor-1 Exerts Time-Dependent Stabilization of Adherens Junctions Following VEGF-Induced Vascular Permeability

  2011cites this paper
• Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog.

  2011cites this paper
• [Epidemiology and pathophysiology of retinopathy of prematurity].

  2011cites this paper
• Protein Kinase B (Akt) Promotes Pathological Angiogenesis in Murine Model of Oxygen-Induced Retinopathy

  2011cites this paper
• Development of a Hypoxia-Induced Zebrafish Choroidal Neovascularization Model

  2011cites this paper
• Selective stimulation of VEGFR2 accelerates progressive renal disease.

  2011cites this paper
• Pulmonary Vascular Remodeling by High Oxygen

  2011cites this paper
• Laser-ranibizumab treatment for retinopathy of prematurity in umbral-preumbral disease. Three years of experience.

  2011cites this paper
• Láser-ranibizumab para tratar retinopatía del prematuro en estadio umbral-preumbral. Tres años de experiencia

  2011cites this paper
• Placental Growth Factor Contributes to Micro-Vascular Abnormalization and Blood-Retinal Barrier Breakdown in Diabetic Retinopathy

  2011cites this paper
• Trasplante de tejido retiniano y de células progenitoras retinianas: una promesa terapéutica para pacientes con enfermedad de la retina

  2010cites this paper
• Plus Disease: Why is it Important in Retinopathy of Prematurity?

  2010cites this paper
• The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model

  2010cites this paper
• Regulation of Pathologic Retinal Angiogenesis in Mice and Inhibition of VEGF-VEGFR2 Binding by Soluble Heparan Sulfate

  2010cites this paper
• Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity.

  2010cites this paper
• Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis).

  2010cites this paper
• The mouse retina as an angiogenesis model.

  2010cites this paper
• Microvascular rarefaction

  2010cites this paper
• MECHANISMS OF MALIGNANT AND NON- MALIGNANT ANGIOGENESIS USING ZEBRAFISH MODELS

  2010cites this paper
• Chapter 72 – Retinopathy of prematurity

  2010cites this paper
• Mechanisms of malignant and non-malignant angiogenesis using zebrafish models

  2010cites this paper
• CHARACTERIZATION OF THE EXPRESSION AND REGULATION OF VEGF AND 4E-BP1 IN THE RETINA DURING DIABETES AND UNDER HYPERGLYCEMIC CONDITIONS

  2009cites this paper
• Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab.

  2009cites this paper
• Retinopathy of Prematurity: Current Concepts in Molecular Pathogenesis

  2009cites this paper
• VEGF-B

  2009cites this paper
• Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.

  2009cites this paper
• Retinopathy of Prematurity: Clinical Insights from Molecular Studies

  2009cites this paper
• Antiangiogenic immunotherapy targeting Flk-1, DNA vaccine and adoptive T cell transfer, inhibits ocular neovascularization.

  2009cites this paper
• Mediators of ocular angiogenesis

  2009cites this paper